Wuhan YZY Biopharma Co Ltd 2023 SR
The report marks the first ESG disclosure for Wuhan YZY Biopharma Co., Ltd., highlighting its commitment to developing innovative bispecific antibody-based therapies. In 2023, the company successfully listed on the HKEX Main Board and invested approximately RMB 155 million in R&D, advancing its core product M701 to Phase III clinical trials. The company established a comprehensive ESG governance framework and set ambitious environmental targets for 2026, including a 10% reduction in per capita water and electricity consumption. YZYBIO also reported zero work-related fatalities and maintained a strong focus on intellectual property, holding 35 granted patents by year-end.
Company: Wuhan YZY Biopharma Co Ltd
Sector: Health Care
Country: China
Year: 2023
Type: SR
Pages: 31
Wuhan YZY Biopharma Co Ltd
ESG Report
The report marks the first ESG disclosure for Wuhan YZY Biopharma Co., Ltd., highlighting its commitment to developing innovative bispecific antibody-based therapies. In 2023, the company successfully listed on the HKEX Main Board and invested approximately RMB 155 million in R&D, advancing its core product M701 to Phase III clinical trials. The company established a comprehensive ESG governance framework and set ambitious environmental targets for 2026, including a 10% reduction in per capita water and electricity consumption. YZYBIO also reported zero work-related fatalities and maintained a strong focus on intellectual property, holding 35 granted patents by year-end.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Workplace Fatalities
Employees